Publications by authors named "Michael M Witte"

Claim this Profile
E
Efficacy and Safety of Lebrikizumab in Combination With Topical Corticosteroids in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial (ADhere).
Eric L Simpson, Melinda Gooderham, Andreas Wollenberg, Stephan Weidinger, April Armstrong, Michael M Witte

JAMA Dermatol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of mirikizumab in psoriasis: results from a 52-week, double-blind, placebo-controlled, randomized withdrawal, phase III trial (OASIS-1).
Andrew Blauvelt, Alexa B Kimball, Matthias Augustin, Yukari Okubo, Michael M Witte

Br J Dermatol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective assessment of patient characteristics and healthcare costs prior to a diagnosis of Alzheimer's disease in an administrative claims database.
Radhika Nair, Virginia S Haynes, Mir Siadaty, Nick C Patel, Adam S Fleisher, Michael M Witte

BMC Geriatr· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Florbetapir F18 PET Amyloid Neuroimaging and Characteristics in Patients With Mild and Moderate Alzheimer Dementia.
Elisabeth K Degenhardt, Michael M Witte, Michael G Case, Peng Yu, David B Henley

Psychosomatics· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship of Hippocampal Volume to Amyloid Burden across Diagnostic Stages of Alzheimer's Disease.
Paula T Trzepacz, Helen Hochstetler, Peng Yu, Peter Castelluccio, Michael M Witte

Dement Geriatr Cogn Disord· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical use of amyloid-positron emission tomography neuroimaging: Practical and bioethical considerations.
Michael M Witte, Norman L Foster, Adam S Fleisher, Monique M Williams, Kimberly Quaid

Alzheimers Dement (Amst)· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Florbetapir positron emission tomography and cerebrospinal fluid biomarkers.
Ann Hake, Paula T Trzepacz, Shufang Wang, Peng Yu, Michael Case, Michael M Witte

Alzheimers Dement· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between clinical measures and florbetapir F18 PET neuroimaging in mild or moderate Alzheimer's disease dementia.
Michael M Witte, Paula Trzepacz, Michael Case, Peng Yu, Helen Hochstetler

J Neuropsychiatry Clin Neurosci· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of neuroimaging modalities for the prediction of conversion from mild cognitive impairment to Alzheimer's dementia.
Paula T Trzepacz, Peng Yu, Jia Sun, Kory Schuh, Michael Case, Michael M Witte

Neurobiol Aging· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of olanzapine long-acting injection in patients with acutely exacerbated schizophrenia: an insight from effect size comparison with historical oral data.
Holland C Detke, Fangyi Zhao, Michael M Witte

BMC Psychiatry· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of gene variants previously associated with iloperidone response in patients with schizophrenia who are treated with risperidone.
Bonnie A Fijal, Virginia L Stauffer, Bruce J Kinon, Robert R Conley, Vicki Poole Hoffmann, Michael M Witte

J Clin Psychiatry· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of atomoxetine on Tanner stage sexual development in children and adolescents with attention deficit/hyperactivity disorder: 18-month results from a double-blind, placebo-controlled trial.
Paula T Trzepacz, Thomas J Spencer, Shuyu Zhang, Mark E Bangs, Michael M Witte

Curr Med Res Opin· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of olanzapine long-acting injection on levels of functioning among acutely ill patients with schizophrenia.
Michael M Witte, Michael G Case, Kory J Schuh, Haya Ascher-Svanum

Curr Med Res Opin· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early response predicts subsequent response to olanzapine long-acting injection in a randomized, double-blind clinical trial of treatment for schizophrenia.
Haya Ascher-Svanum, Fangyi Zhao, Holland C Detke, Allen W Nyhuis, Anthony H Lawson, Michael M Witte

BMC Psychiatry· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and tolerability of atomoxetine over 3 to 4 years in children and adolescents with ADHD.
Craig Donnelly, Mark Bangs, Paula Trzepacz, Ling Jin, Shuyu Zhang, Michael M Witte

J Am Acad Child Adolesc Psychiatry· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of comorbid symptoms of oppositional defiant disorder on responses to atomoxetine in children with ADHD: a meta-analysis of controlled clinical trial data.
Joseph Biederman, Thomas J Spencer, Jeffrey H Newcorn, Haitao Gao, Denái R Milton, Michael M Witte

Psychopharmacology (Berl)· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two distinct domains within the N-terminal region of Janus kinase 1 interact with cytokine receptors.
Anna Usacheva, Sergei Kotenko, Michael M Witte, Oscar R Colamonici

J Immunol· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
P2P-R protein localizes to the nucleolus of interphase cells and the periphery of chromosomes in mitotic cells which show maximum P2P-R immunoreactivity.
Sizhi Gao, Michael M Witte, Robert E Scott

J Cell Physiol· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis